TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Envor Biotech Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover | 42,688 | 49,393 | 56,827 |
Financial expenses | 1,521 | 1,288 | 1,532 |
Earnings before taxes | -4,248 | -4,732 | -19 |
Total assets | 66,672 | 67,626 | 75,372 |
Current assets | 153 | 210 | 343 |
Current liabilities | 49,748 | 43,017 | 38,081 |
Equity capital | 13,939 | 14,936 | 15,643 |
- share capital | 832 | 795 | 828 |
Employees (average) | 6 | 5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency | 20.9% | 22.1% | 20.8% |
Turnover per employee | 8,232 | 11,365 | |
Profit as a percentage of turnover | -10.0% | -9.6% | 0.0% |
Return on assets (ROA) | -4.1% | -5.1% | 2.0% |
Current ratio | 0.3% | 0.5% | 0.9% |
Return on equity (ROE) | -30.5% | -31.7% | -0.1% |
Change turnover | -9,041 | -5,161 | 15,244 |
Change turnover % | -17% | -9% | 37% |
Chg. No. of employees | 1 | -1 | |
Chg. No. of employees % | 20% | -17% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.